Litcius/Paper detail

Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation

Zhuyu Luo, Qiao Li, Shan He, Suqing Liu, Rui Lei, Qing Kong, Ruilong Wang, Xiao Liu, Jinfeng Wu, Jinfeng Wu

2024International Immunopharmacology11 citationsDOI

Topics & Concepts

BerberineBlockadeImmune checkpointMelanomaCancer researchChemistryMedicinePharmacologyInternal medicineReceptorBerberine and alkaloids researchEndoplasmic Reticulum Stress and DiseasePharmacological Receptor Mechanisms and Effects
Berberine sensitizes immune checkpoint blockade therapy in melanoma by NQO1 inhibition and ROS activation | Litcius